Home/Filings/4/0001562180-25-002198
4//SEC Filing

McShane Geri-Michelle 4

Accession 0001562180-25-002198

CIK 0001524472other

Filed

Mar 6, 7:00 PM ET

Accepted

Mar 7, 4:14 PM ET

Size

9.1 KB

Accession

0001562180-25-002198

Insider Transaction Report

Form 4
Period: 2025-03-07
McShane Geri-Michelle
VP, Controller & CAO
Transactions
  • Sale

    Common Stock

    2025-03-07$128.18/sh4,119$527,9783,950 total
  • Exercise/Conversion

    Common Stock

    2025-03-07$80.66/sh+3,119$251,5798,069 total
  • Exercise/Conversion

    Non-Qualified Stock Options (Right to Buy)

    2025-03-073,1190 total
    Exercise: $80.66Exp: 2030-02-27Common Stock (3,119 underlying)
Footnotes (2)
  • [F1]This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 4,119 Shares were executed at a range of prices from $127.50 to $128.38. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.
  • [F2]The February 27, 2020 option grant vested 1,030 options on February 27, 2021, 1,029 options on February 27, 2022, and 1,060 options on February 27, 2023.

Issuer

Xylem Inc.

CIK 0001524472

Entity typeother

Related Parties

1
  • filerCIK 0001769064

Filing Metadata

Form type
4
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 4:14 PM ET
Size
9.1 KB